228 related articles for article (PubMed ID: 28274359)
1. Demodex and rosacea revisited.
Moran EM; Foley R; Powell FC
Clin Dermatol; 2017; 35(2):195-200. PubMed ID: 28274359
[TBL] [Abstract][Full Text] [Related]
2. Additional evidence that rosacea pathogenesis may involve demodex: new information from the topical efficacy of ivermectin and praziquantel.
Abokwidir M; Fleischer AB
Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437294
[TBL] [Abstract][Full Text] [Related]
3. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea.
Schaller M; Gonser L; Belge K; Braunsdorf C; Nordin R; Scheu A; Borelli C
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1907-1911. PubMed ID: 28653460
[TBL] [Abstract][Full Text] [Related]
4. The treatment of rosacea with topical ivermectin.
Ali ST; Alinia H; Feldman SR
Drugs Today (Barc); 2015 Apr; 51(4):243-50. PubMed ID: 26020066
[TBL] [Abstract][Full Text] [Related]
5. The Demodex mite population in rosacea.
Bonnar E; Eustace P; Powell FC
J Am Acad Dermatol; 1993 Mar; 28(3):443-8. PubMed ID: 8445060
[TBL] [Abstract][Full Text] [Related]
6. Real-life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites.
Trave I; Merlo G; Cozzani E; Parodi A
Dermatol Ther; 2019 Nov; 32(6):e13093. PubMed ID: 31579993
[TBL] [Abstract][Full Text] [Related]
7. Severe demodexfolliculorum-associated oculocutaneous rosacea in a girl successfully treated with ivermectin.
Brown M; Hernández-Martín A; Clement A; Colmenero I; Torrelo A
JAMA Dermatol; 2014 Jan; 150(1):61-3. PubMed ID: 24284904
[TBL] [Abstract][Full Text] [Related]
8. [A dog related Demodex spp. infestation in a student: a rare Demodex case].
Esenkaya Taşbent F; Dik B
Mikrobiyol Bul; 2018 Apr; 52(2):214-220. PubMed ID: 29933739
[TBL] [Abstract][Full Text] [Related]
9. Monitoring structural changes in Demodex mites under topical Ivermectin in rosacea by means of reflectance confocal microscopy: a case series.
Ruini C; Sattler E; Hartmann D; Reinholz M; Ruzicka T; von Braunmühl T
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e299-e301. PubMed ID: 27976437
[No Abstract] [Full Text] [Related]
10. Are Demodex mites principal, conspirator, accomplice, witness or bystander in the cause of rosacea?
Chen W; Plewig G
Am J Clin Dermatol; 2015 Apr; 16(2):67-72. PubMed ID: 25666117
[TBL] [Abstract][Full Text] [Related]
11. Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea.
Lacey N; Russell-Hallinan A; Zouboulis CC; Powell FC
Br J Dermatol; 2018 Aug; 179(2):420-430. PubMed ID: 29532463
[TBL] [Abstract][Full Text] [Related]
12. Demodex mites in acne rosacea.
Roihu T; Kariniemi AL
J Cutan Pathol; 1998 Nov; 25(10):550-2. PubMed ID: 9870674
[TBL] [Abstract][Full Text] [Related]
13. Rosacea: Treatment targets based on new physiopathology data.
Cribier B
Ann Dermatol Venereol; 2022 Jun; 149(2):99-107. PubMed ID: 34893359
[TBL] [Abstract][Full Text] [Related]
14. An emerging treatment: Topical ivermectin for papulopustular rosacea.
Abokwidir M; Fleischer AB
J Dermatolog Treat; 2015; 26(4):379-80. PubMed ID: 25424053
[TBL] [Abstract][Full Text] [Related]
15. Study of Demodex mites: Challenges and Solutions.
Lacey N; Russell-Hallinan A; Powell FC
J Eur Acad Dermatol Venereol; 2016 May; 30(5):764-75. PubMed ID: 26695086
[TBL] [Abstract][Full Text] [Related]
16. Potential role of Demodex mites and bacteria in the induction of rosacea.
Jarmuda S; O'Reilly N; Żaba R; Jakubowicz O; Szkaradkiewicz A; Kavanagh K
J Med Microbiol; 2012 Nov; 61(Pt 11):1504-1510. PubMed ID: 22933353
[TBL] [Abstract][Full Text] [Related]
17. Clinical applications of topical ivermectin in dermatology.
Zargari O; Aghazadeh N; Moeineddin F
Dermatol Online J; 2016 Sep; 22(9):. PubMed ID: 28329606
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of the prevalance of Demodex folliculorum and Demodex brevis in rosacea patients].
Yücel A; Yilmaz M
Turkiye Parazitol Derg; 2013; 37(3):195-8. PubMed ID: 24192622
[TBL] [Abstract][Full Text] [Related]
19. Ivermectin 1% (CD5024) for the treatment of rosacea.
Sahni DR; Feldman SR; Taylor SL
Expert Opin Pharmacother; 2018 Apr; 19(5):511-516. PubMed ID: 29544355
[TBL] [Abstract][Full Text] [Related]
20. Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications.
Kircik LH; Del Rosso JQ; Layton AM; Schauber J
J Drugs Dermatol; 2016 Mar; 15(3):325-32. PubMed ID: 26954318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
